Literature DB >> 20019185

Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.

Massimo Tabaton1, George Perry, Xiongwei Zhu, Hyoung-gon Lee, Gemma Casadesus, Mark A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20019185      PMCID： PMC2808061          DOI： 10.2353/ajpath.2010.090856

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  11 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 2.  Memantine for dementia.

Authors:  Sastre A Areosa; F Sherriff; R McShane
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 3.  Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.

Authors:  Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Acta Neuropathol       Date:  2006-04-27       Impact factor: 17.088

4.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

5.  Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Authors:  Gordon K Wilcock; Sandra E Black; Suzanne B Hendrix; Kenton H Zavitz; Edward A Swabb; Mark A Laughlin
Journal:  Lancet Neurol       Date:  2008-04-29       Impact factor: 44.182

6.  Myriad stumbles, Wyeth closes on Alzheimer's.

Authors:  Randy Osborne
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

7.  Progress in Alzheimer's disease drug discovery: an update.

Authors:  Michael Williams
Journal:  Curr Opin Investig Drugs       Date:  2009-01

Review 8.  Amyloid beta: the alternate hypothesis.

Authors:  Hyoung-gon Lee; Xiongwei Zhu; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Curr Alzheimer Res       Date:  2006-02       Impact factor: 3.498

9.  Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.

Authors:  Hilda Martinez-Coria; Kim N Green; Lauren M Billings; Masashi Kitazawa; Miriam Albrecht; Gerhard Rammes; Chris G Parsons; Sandeep Gupta; Pradeep Banerjee; Frank M LaFerla
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

10.  Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

Authors:  Clive Holmes; Delphine Boche; David Wilkinson; Ghasem Yadegarfar; Vivienne Hopkins; Anthony Bayer; Roy W Jones; Roger Bullock; Seth Love; James W Neal; Elina Zotova; James A R Nicoll
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321
View more
  1 in total

1.  Memantine for dementia.

Authors:  Rupert McShane; Maggie J Westby; Emmert Roberts; Neda Minakaran; Lon Schneider; Lucy E Farrimond; Nicola Maayan; Jennifer Ware; Jean Debarros
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.